Search Results
Results found for "Jana Selent"
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Our results suggest that strategies to selectively target OGR1 expression may represent a novel therapeutic
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
The conformation-selective antibody, Fab30, promotes partially activated βarr into the activated-like
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
available to study the contribution of PKC isozymes have considerable limitations, including a lack of selectivity
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Pc(4-4), a lead backbone cyclic peptide, was selected out of a mini-library, directed toward PAR2&4 PH-binding
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
protein-biased GPR3 mouse model to investigate the physiological and pathophysiological consequences of selective
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
mechanistic insights of our study provide clues for the future design of isoform-specific GPR35 ligands that selectively
- From Pipettes to Platforms: The Evolution of GPCR Research
a starting point for more ambitious questions about GPCR networks, biased signaling, and functional selectivity
- Molecular creativity in drug discovery
And that matter shapes everything: selectivity, safety, efficacy, and innovation.
- 📰 GPCR Weekly News
targets Constitutive activity of the dopamine receptor D5R, highly expressed in CA1 hippocampal neurons, selectively
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Yamina’s Corner reveals how fragmented data, undefined workflows, and ambiguous decision gates silently
- Why “Displacement” Misleads You: Allosteric Binding Demystified
If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Cannabinoid 1 (CB1 ) receptor arrestin subtype-selectivity and phosphorylation dependence. GPCR Binders, Drugs, and more Ligands selectively tune the local and global motions of neurotensin receptor
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Platform selection shapes interpretation. Infrastructure influences velocity.
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Highly selective filters can streamline resource allocation Early elimination of unsafe scaffolds prevents
- 📰 GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
Individual cancer types were enriched for highly impactful, recurrent mutations at selected cognate positions
- 📰 GPCR Weekly News, October 2 to 8, 2023
determined by NMR via Methyl Relaxation Structural determinants of sphingosine-1-phosphate receptor selectivity
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
From t-test, ANOVA, F-test selection to power analysis that prevents underpowered studies, this module
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
The impact of ACEA is inhibited by the selective CB1 receptor antagonist, rimonabant.
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
from β-arrestin interaction and demonstrates altered regulatory outcomes downstream of this functional selectivity
- 📰 GPCR Weekly News, July 10 to 16, 2023
The potent BECN2-ATG14 coiled-coil interaction is selectively critical for endolysosomal degradation
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
. 📝 Manuscript summary deadline: 23 Sept 2025 📄 Submission deadline: 11 Jan 2026 Submit to Volume II Join the conversation on computational targeting and next-gen selectivity.
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
Synthetic signaling platforms permitting precise and selective Ca2+ signal transduction can improve dissection
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Kenakin argues, every downstream variable becomes distorted —from preclinical modeling to dose selection
- 📰 GPCR Weekly News, May 15 to 21, 2023
GPCRs in Neuroscience Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
A ligand-based peptide probe could, offer the consistency and surface selectivity GPCR imaging demands
- 📰 GPCR Weekly News, August 7 to 13, 2023
Submit your abstracts for poster presentation using this form - short talks will be selected from these
- 📰 GPCR Weekly News - January 2 to 8, 2023
Industry News Arcoscreen selected by START Lausanne to pitch at the START Global summit on the 23-24th
- Interacting binding insights and conformational consequences of the differential activity of...
In contrast, when the GPR55 receptor is simulated in complex with the selective agonist ML186, agonist-like
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
, you’ll learn how dialing receptor expression/coupling up or down reveals hidden partial agonism, “silent












